Replies to post #55931 on RespireRx Pharmaceuticals Inc (fka RSPI)

[LTListener]

For being bored, you really are concerned. Almost like you have a position in this company…. Hedged or short maybe?

I think the subsidiaries will get assets and funding committed based upon asset values, like ResolutionRx has some funding committed.

You really need to start looking into the science and understand the significance of KRM-ll-81 progress. Let alone the other assets.

[LTListener]

“Castle started their due diligence several months ago? And it resulted in their believing that they could raise $45million on behalf of this Expert Market Company?”

Have you seen what Saniona got in a deal with Acadia for a similar selective gabakine? KRM-ll-81 has a much more extensive and robust preclinical profile.

[Golaop]

Jeff probably misunderstood (or chose to interpret narrowly) what the SEC meant by “failed to heed.” He equated “heed” with “notice and respond” rather than “take the corrective action required.”